IRUBIS
IRUBIS GmbH is a Munich-based startup founded by Anja Müller, Alexander Geißler and Lorenz Sykora-Mirle in 2017. IRUBIS has developed Monipa to bring biological drugs faster to the market. This process analytical technology improves process development and manufacturing of biopharmaceuticals. Monipa is a mid-infrared spectrometer system that enables real-time monitoring and control of important parameters in bioprocessing. It’s single-use interface and the simplifying calibration model, revolutionizes the bioprocess industry. Monipa is already in use by key opinion leaders in the biopharma industry.
Press releases
Press
Real-Time Monitoring of Bioprocesses: IRUBIS closes EUR 2.8m seed round led by HTGF, Verve Ventures and Ventura BioMed Investors
Biotech startup IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene.
Munich, 6 October 2022 – IRUBIS was founded in September 2017 by Lorenz Sykora, Alexander Geißler and Anja Müller with the goal to automate the process d
Info & Contact
Address
IRUBIS GmbH
Schillerstr. 40B,
80336 München
Schillerstr. 40B,
80336 München